Archives
-
Super-Resolution Maps Organelle Proximity
2026-10-13
Ren et al. describe a conceptual workflow that combines live-cell super-resolution imaging, machine-learning-assisted segmentation and morphology-based distance analysis to study organelle spatial proximity. Its value is strongest as a quantitative imaging framework, while claims about biological contact sites remain bounded by optical resolution, labeling assumptions and the distinction between proximity and molecular tethering.
-
EGFP mRNA m1Ψ: Evidence and Boundaries
2026-10-12
EGFP mRNA m1Ψ is best understood as a reporter construct for studying RNA delivery and protein expression, not as evidence that one RNA-engineering strategy applies across all RNA classes. The supplied telomerase study illustrates why cap chemistry, nucleoside modification and 3′-end stabilization must be interpreted in relation to transcript function and structure.
-
EGFP mRNA m1Ψ: Evidence and Scope
2026-10-12
EGFP mRNA m1Ψ combines an EGFP reporter sequence with a Cap 1 5′ end and N1-methylpseudouridine, features intended to support translation and reduce recognition of synthetic RNA. The supplied evidence supports a mechanistic rationale and a research-reporting use case, but does not establish performance for a specific product across cell types, delivery systems, or in vivo settings.
-
EZ Cap EGFP mRNA: Evidence and Boundaries
2026-10-11
EZ Cap EGFP mRNA is described by APExBIO as a Cap 1 EGFP reporter mRNA for research applications involving delivery and transient expression. A murine dendritic-cell study supports electroporated reporter mRNA as a way to assess genetic modification and downstream antigen-presentation questions, but its findings do not establish product equivalence, clinical utility, or applicability across cell types.
-
GM 6001 (Galardin): Evidence and Research Context
2026-10-10
GM 6001, also known as Galardin, is a broad-spectrum matrix metalloproteinase inhibitor used as a research tool for studying extracellular matrix remodeling, cell signaling, tissue repair, and vascular responses. This overview separates supplier-reported activity from directly documented study evidence and explains why findings from an unrelated SGI-1027 renal cancer study should not be attributed to GM 6001.
-
ELAVL3–MYCN Feedback in Neuroendocrine Prostate Cancer
2026-10-09
The reference study identifies an ELAVL3–MYCN positive feedback loop that helps sustain neuroendocrine differentiation and progression in neuroendocrine prostate cancer. Its preclinical findings position ELAVL3 as a mechanistically relevant vulnerability, while also highlighting the need for clinical validation and more selective pharmacological approaches.
-
PKM2 Inhibitor Compound 3k: Evidence Overview
2026-10-09
A source-grounded overview of PKM2 inhibitor (compound 3k), covering its proposed metabolic mechanism, reported findings in severe acute pancreatitis and cancer models, evidence provenance, conceptual applications, and key limitations.
-
Enhanced EZ Cap™ EGFP mRNA: Evidence Guide
2026-10-08
Enhanced EZ Cap™ EGFP mRNA (m1Ψ) can serve as a reporter cargo for studying RNA delivery, but its fluorescence must be interpreted as a multi-step biological readout. This evidence-focused guide connects reporter mRNA design with the 2025 potato virus X nucleoprotein platform study while defining what the findings do—and do not—establish.
-
From EGFP Editing to Translational Confidence
2026-10-08
Multiplexed CRISPR is moving from a technical capability to a question of evidence quality. Using EGFP-targeting reagents in HeLa as a model system, this article examines mechanistic rationale, validation logic, translational boundaries, and how researchers can interpret multiplexed editing without confusing a visible reporter response with genome-engineering certainty.
-
Mitochondrial Remodeling: From PFKM to ER Signaling
2026-10-07
A translational interpretation of how PFKM links glycolytic state, ER–mitochondria communication, and mitochondrial quality control during osteogenesis. The article also explains where an ER-focused fluorescent mRNA probe can add biological context without overstating what it can measure.
-
Adamtsl3, MMP9, and Adult Cortical Plasticity
2026-10-07
A 2026 Molecular Psychiatry study identifies Adamtsl3 as a cell-autonomous regulator of perineuronal-net integrity in parvalbumin-positive interneurons. Mouse genetic, imaging, biochemical, rescue, and plasticity evidence links Adamtsl3 loss to excess MMP9 activity, reduced Otx2 uptake, oxidative stress, and renewed juvenile-like cortical plasticity.
-
MRSA EVs and IL-8-Dependent OSCC Growth
2026-10-06
A 2026 study identifies extracellular vesicles from methicillin-resistant Staphylococcus aureus as active drivers of oral squamous cell carcinoma proliferation, distinguishing their effects from vesicles produced by methicillin-susceptible S. aureus. The reported ERK/c-Jun–IL-8–CXCR1 signaling relationship broadens the study of antibiotic-resistant bacteria in cancer biology while remaining limited by preclinical models and unresolved pathway details.
-
ZCL278 and Cdc42: Evidence and Research Context
2026-10-06
A source-grounded overview of ZCL278 as a reported selective Cdc42 inhibitor, its relevance to cell motility and neuronal morphology, and why recent kidney-fibrosis findings with daphnepedunin A should not be interpreted as direct evidence for ZCL278.
-
SINAT–VAB1 Control of Plant Autophagy
2026-10-05
A 2026 Arabidopsis study identifies VAB1, a V-ATPase subunit, as a direct SINAT-associated regulator of autophagic vesicle degradation. The findings connect SINAT-dependent ubiquitination of VAB1 with vacuolar acidification, nutrient-starvation tolerance, and leaf senescence, extending plant autophagy research beyond autophagosome formation.
-
Ac-YVAD-CMK in Caspase-1 and Liver Inflammation
2026-10-05
Ac-YVAD-CMK, also known as N-Ac-Tyr-Val-Ala-Asp-CMK, is commonly described as a caspase-1-targeting research compound. This overview places that pharmacological claim alongside a 2024 mouse study showing that Kupffer-cell TMEM16F protects against Listeria-associated liver injury. The evidence supports a conceptual separation of cytokine maturation, membrane repair, and inflammatory cell death, but does not establish that Ac-YVAD-CMK was tested in the study or that it would reproduce its genetic findings.